Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 40.39M | -17.03M | -24.61M | -25.35M | -49.50M |
| Total Depreciation and Amortization | 6.71M | 5.00M | 4.79M | 4.68M | 4.96M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.46M | 11.94M | 18.70M | 17.14M | 33.58M |
| Change in Net Operating Assets | 3.01M | -4.98M | 7.56M | -5.35M | -5.48M |
| Cash from Operations | -42.36M | 1.29M | 12.79M | -2.52M | -10.09M |
| Capital Expenditure | -12.40M | -9.50M | -23.37M | -21.56M | -17.00M |
| Sale of Property, Plant, and Equipment | 76.00K | 76.00K | 12.00K | 7.00K | 138.00K |
| Cash Acquisitions | -65.17M | 0.00 | 0.00 | 0.00 | -- |
| Divestitures | -1.24M | -- | -- | -- | -- |
| Other Investing Activities | 134.20M | 62.49M | 30.83M | 33.19M | 24.59M |
| Cash from Investing | 55.46M | 40.42M | -5.17M | -1.02M | -4.92M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 183.00K | 118.00K | 126.00K | 157.00K | 120.00K |
| Repurchase of Common Stock | -11.23M | -9.38M | -9.45M | -5.19M | -1.30M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.04M | -9.99M | -10.06M | -5.76M | -1.91M |
| Foreign Exchange rate Adjustments | -448.00K | 168.00K | 10.00K | -142.00K | -18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.61M | 31.95M | -2.37M | -9.37M | -16.87M |